Company Filing History:
Years Active: 1995-2017
Title: Michael Reinhardt: Innovator in Thrombus Imaging Technologies
Introduction
Michael Reinhardt is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical imaging, particularly in the development of compounds for thrombus imaging. With a total of 4 patents, his work has advanced diagnostic techniques in the medical community.
Latest Patents
Reinhardt's latest patents focus on compounds that bind to the platelet-specific glycoprotein IIb/IIIa. These inventions are crucial for imaging thrombi using positron emission tomography (PET). The first patent describes novel fluorine-containing compounds and methods for their preparation, which serve as diagnostic agents for imaging thrombi in mammalian bodies. The second patent also relates to similar compounds and methods, emphasizing the importance of high-affinity, specific-binding glycoprotein IIb/IIIa antagonists for effective imaging.
Career Highlights
Throughout his career, Michael Reinhardt has worked with prominent companies in the pharmaceutical and imaging sectors. Notably, he has been associated with Schering Aktiengesellschaft and Piramal Imaging SA. His experience in these organizations has contributed to his expertise in developing innovative imaging solutions.
Collaborations
Reinhardt has collaborated with several professionals in his field, including Markus Berger and Martin Kruger. These partnerships have likely enhanced the quality and impact of his inventions.
Conclusion
Michael Reinhardt's contributions to thrombus imaging technologies demonstrate his commitment to advancing medical diagnostics. His innovative patents and collaborations reflect his significant role in the field.